Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations

NCT01430403 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

478

Enrollment

NIH

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Omalizumab
DRUG: Inhaled Corticosteroid Boost Therapy (ICS)
BIOLOGICAL: Placebo omalizumab
BIOLOGICAL: Placebo fluticasone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]